Admission Date:  [**2118-7-9**]              Discharge Date:   [**2118-7-30**]  Date of Birth:  [**2058-3-9**]             Sex:   F  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 7591**] Chief Complaint: Febrile neutropenia   Major Surgical or Invasive Procedure: PICC placement [**2118-7-11**] Bone Marrow Biopsy [**2118-7-24**]   History of Present Illness: 60yo woman with mantle cell lymphoma s/p RICE (day 1 [**6-29**]) who presented to the ED with approximately 24h of nausea,vomiting, fever to 102 and loose stools.
Patient received total of 3 L of IVF and electrolyte repletion for Magnesium and POtassium.
Past Medical History: Oncologic Hx: - dx mantle cell lymphoma in [**2114**] - completed four cycles of R-CHOP followed by Zevalin by [**4-9**] - progressed by [**7-11**] -> began velcade/rituxan ** had L cervical LN - again progressed by 5th cycle velcade/rituxan/dex in L cervical LN - admitted for [**Hospital1 **] on [**2117-12-11**], [**2118-1-10**] and R-[**Hospital1 **] on [**2118-2-4**] - PET showed good response initially - planned for autoSCT on [**2118-3-15**] but CT on admit showed progressive dz - received ESHAP w/ plans for autoSCT if dz stable post ESHAP - PET on [**2118-4-11**] reported progression of her disease - BMB on [**2118-3-15**] showed a mildly hypocellular marrow with trilineage hematopoiesis, no evidence of mantle cell, NL cytogenetics - admitted for 2nd cycle of ESHAP [**Date range (1) 57305**] - given rituxan on [**5-6**] and 3rd cycle ESHAP [**Date range (1) 57306**] - C1D1 Rituxan/Bendamustine on [**2118-6-6**] - CT showed disease progression [**2118-6-28**] .
Patient was continued on her outpatient regimen of prophylactic Acyclovir.
She was started on Atovaquone 1500mg PO daily for PCP prophylaxis and discharged on both of these medications.
However, on [**7-29**] she had an acute episode of stridor/dysphagia that resolved after steroids and benadryl.
At time of discharge patient was able to eat soft solids and thin liquids without no issues.
She was discharged with a two day course of Prednisone 40 mg PO daily and received one dose prior to discharge.
Dr. [**Last Name (STitle) 410**] and Rad Onc can decided whether further steroid therapy is necessary.
Patient was discharged with Atorvastatin and Metoprolol.
These medications should continue to be managed as an outpatient and pt should follow up with her primary care physician regarding stress test.
6) Electrolyte Repletion: Patient was continued on Potassium and Magnesium replacement which were determined based on her needs as an inpatient.
Medications on Admission: Allopurinol 300 daily ativan 0.5 q6h prn compazine 10 q8h prn Potassium 20 daily mag oxide 800 [**Hospital1 **] albuterol prn benzonatate 100 tid acyclovir 400 tid  Discharge Medications: 1.
Acyclovir 200 mg Capsule Sig: Two (2) Capsule PO TID (3 times a day).
Allopurinol 300 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Atorvastatin 80 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Atovaquone 750 mg/5 mL Suspension Sig: 10 mL  PO DAILY (Daily).
Prednisone 20 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily) for 2 days.
Magnesium Oxide 400 mg Tablet Sig: Two (2) Tablet PO once a day.
Potassium Chloride 20 mEq Packet Sig: 20 mEq  PO twice a day.
Omeprazole 20 mg Capsule, Delayed Release(E.C.)
We gave you antibiotics and the infection resolved.
We started you on two new medications for you heart.
We treated you with antibiotics and this infection improved, as well.
You still have ulcers in your genital and rectal area which you should continue treating with daily [**Last Name (un) **] baths and application of bacitracin covered by gauze.
You were seen by speech and swallow who recommended that you eat soft solids and thin liquids, take sips after each bite, and tuck your chin when swallowing.
2) Atorvastatin: This medication reduces cholesterol and also helps to protect your heart function.
